Ultramed Ltd has HMRC pre-approval with the Seed Enterprise Investment Scheme (SEIS). Subject to continued compliance with the investment regulations this gives investors 50% income tax relief on their investment.
A first round of SEIS investment was fully subscribed in March 2016. This investment funding is being used to increase Ultramed’s marketing.
A second round of SEIS investment is now available. This will be used for further product developments. It is intended to seek grant funding to ‘match’ with the investment funding to produce a substantial product development resource.
Ultramed is looking for investors who will bring either clinical or commercial experience to the company as well as their investment. This will be in the form of a non-executive role giving advice as required.
For further details of this exciting investment opportunity please contact email@example.com